| GO:0006351 | transcription, DNA-templated | 9.59% (14/146) | 2.29 | 1e-06 | 6e-05 |
| GO:0097659 | nucleic acid-templated transcription | 9.59% (14/146) | 2.29 | 1e-06 | 6e-05 |
| GO:0032774 | RNA biosynthetic process | 9.59% (14/146) | 2.19 | 3e-06 | 8.6e-05 |
| GO:0003677 | DNA binding | 10.96% (16/146) | 2.02 | 2e-06 | 9e-05 |
| GO:0043227 | membrane-bounded organelle | 9.59% (14/146) | 2.0 | 1.1e-05 | 0.000108 |
| GO:0043231 | intracellular membrane-bounded organelle | 9.59% (14/146) | 2.0 | 1.1e-05 | 0.000108 |
| GO:0033647 | host intracellular organelle | 8.9% (13/146) | 2.1 | 1.1e-05 | 0.00012 |
| GO:0033648 | host intracellular membrane-bounded organelle | 8.9% (13/146) | 2.1 | 1.1e-05 | 0.00012 |
| GO:0033643 | host cell part | 8.9% (13/146) | 2.1 | 1.1e-05 | 0.00012 |
| GO:0033646 | host intracellular part | 8.9% (13/146) | 2.1 | 1.1e-05 | 0.00012 |
| GO:0018995 | host cellular component | 8.9% (13/146) | 2.1 | 1.1e-05 | 0.00012 |
| GO:0042025 | host cell nucleus | 8.9% (13/146) | 2.1 | 1.1e-05 | 0.00012 |
| GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | 8.9% (13/146) | 2.18 | 6e-06 | 0.000131 |
| GO:0005634 | nucleus | 9.59% (14/146) | 2.11 | 5e-06 | 0.000133 |
| GO:0018130 | heterocycle biosynthetic process | 10.27% (15/146) | 1.99 | 6e-06 | 0.000137 |
| GO:0003700 | DNA-binding transcription factor activity | 8.9% (13/146) | 2.05 | 1.6e-05 | 0.000145 |
| GO:1901362 | organic cyclic compound biosynthetic process | 10.27% (15/146) | 1.95 | 8e-06 | 0.000148 |
| GO:0034654 | nucleobase-containing compound biosynthetic process | 9.59% (14/146) | 2.03 | 9e-06 | 0.000152 |
| GO:0008270 | zinc ion binding | 12.33% (18/146) | 1.95 | 1e-06 | 0.00016 |
| GO:0046914 | transition metal ion binding | 13.7% (20/146) | 1.52 | 2e-05 | 0.000163 |
| GO:0019438 | aromatic compound biosynthetic process | 9.59% (14/146) | 1.93 | 2e-05 | 0.000169 |
| GO:0140110 | transcription regulator activity | 8.9% (13/146) | 1.96 | 3.2e-05 | 0.000247 |
| GO:0034645 | cellular macromolecule biosynthetic process | 9.59% (14/146) | 1.78 | 5.7e-05 | 0.000408 |
| GO:0044260 | cellular macromolecule metabolic process | 13.7% (20/146) | 1.42 | 5.7e-05 | 0.000423 |
| GO:0031326 | regulation of cellular biosynthetic process | 8.9% (13/146) | 1.81 | 8.9e-05 | 0.000462 |
| GO:2000112 | regulation of cellular macromolecule biosynthetic process | 8.9% (13/146) | 1.81 | 8.9e-05 | 0.000462 |
| GO:0009889 | regulation of biosynthetic process | 8.9% (13/146) | 1.81 | 8.9e-05 | 0.000462 |
| GO:0010556 | regulation of macromolecule biosynthetic process | 8.9% (13/146) | 1.81 | 8.9e-05 | 0.000462 |
| GO:0003676 | nucleic acid binding | 12.33% (18/146) | 1.46 | 9.5e-05 | 0.000468 |
| GO:0010468 | regulation of gene expression | 8.9% (13/146) | 1.8 | 9.4e-05 | 0.000475 |
| GO:0006355 | regulation of transcription, DNA-templated | 8.9% (13/146) | 1.82 | 8.1e-05 | 0.000483 |
| GO:1903506 | regulation of nucleic acid-templated transcription | 8.9% (13/146) | 1.82 | 8.1e-05 | 0.000483 |
| GO:0051252 | regulation of RNA metabolic process | 8.9% (13/146) | 1.82 | 8.1e-05 | 0.000483 |
| GO:2001141 | regulation of RNA biosynthetic process | 8.9% (13/146) | 1.82 | 8.1e-05 | 0.000483 |
| GO:0019219 | regulation of nucleobase-containing compound metabolic process | 8.9% (13/146) | 1.82 | 8.1e-05 | 0.000483 |
| GO:0080090 | regulation of primary metabolic process | 8.9% (13/146) | 1.77 | 0.000114 | 0.000516 |
| GO:0051171 | regulation of nitrogen compound metabolic process | 8.9% (13/146) | 1.77 | 0.000114 | 0.000516 |
| GO:0031323 | regulation of cellular metabolic process | 8.9% (13/146) | 1.77 | 0.000117 | 0.000517 |
| GO:0043169 | cation binding | 13.7% (20/146) | 1.32 | 0.000137 | 0.000537 |
| GO:0016070 | RNA metabolic process | 9.59% (14/146) | 1.67 | 0.000135 | 0.000541 |
| GO:0009059 | macromolecule biosynthetic process | 9.59% (14/146) | 1.69 | 0.000114 | 0.000542 |
| GO:0019222 | regulation of metabolic process | 8.9% (13/146) | 1.75 | 0.000134 | 0.00055 |
| GO:0060255 | regulation of macromolecule metabolic process | 8.9% (13/146) | 1.75 | 0.000134 | 0.00055 |
| GO:0046872 | metal ion binding | 13.7% (20/146) | 1.33 | 0.000133 | 0.00057 |
| GO:0046483 | heterocycle metabolic process | 11.64% (17/146) | 1.39 | 0.000264 | 0.000968 |
| GO:0043229 | intracellular organelle | 9.59% (14/146) | 1.57 | 0.000263 | 0.000984 |
| GO:0043226 | organelle | 9.59% (14/146) | 1.57 | 0.000263 | 0.000984 |
| GO:0044271 | cellular nitrogen compound biosynthetic process | 9.59% (14/146) | 1.56 | 0.000282 | 0.001009 |
| GO:0006139 | nucleobase-containing compound metabolic process | 10.96% (16/146) | 1.4 | 0.000371 | 0.001303 |
| GO:1901360 | organic cyclic compound metabolic process | 11.64% (17/146) | 1.34 | 0.000403 | 0.001386 |
| GO:0050794 | regulation of cellular process | 8.9% (13/146) | 1.53 | 0.000587 | 0.001978 |
| GO:0050789 | regulation of biological process | 8.9% (13/146) | 1.51 | 0.000667 | 0.002207 |
| GO:0090304 | nucleic acid metabolic process | 9.59% (14/146) | 1.43 | 0.000711 | 0.002306 |
| GO:0043167 | ion binding | 20.55% (30/146) | 0.87 | 0.000726 | 0.002311 |
| GO:0044249 | cellular biosynthetic process | 10.27% (15/146) | 1.32 | 0.000989 | 0.003038 |
| GO:0006725 | cellular aromatic compound metabolic process | 10.96% (16/146) | 1.27 | 0.000987 | 0.003085 |
| GO:0065007 | biological regulation | 8.9% (13/146) | 1.44 | 0.001049 | 0.003166 |
| GO:1901576 | organic substance biosynthetic process | 10.27% (15/146) | 1.31 | 0.001098 | 0.003256 |
| GO:0006807 | nitrogen compound metabolic process | 15.75% (23/146) | 0.98 | 0.001232 | 0.003593 |
| GO:1901363 | heterocyclic compound binding | 19.86% (29/146) | 0.84 | 0.001351 | 0.003808 |
| GO:0097159 | organic cyclic compound binding | 19.86% (29/146) | 0.84 | 0.001351 | 0.003808 |
| GO:0140056 | organelle localization by membrane tethering | 1.37% (2/146) | 4.99 | 0.001589 | 0.004142 |
| GO:0022406 | membrane docking | 1.37% (2/146) | 4.99 | 0.001589 | 0.004142 |
| GO:0048278 | vesicle docking | 1.37% (2/146) | 4.99 | 0.001589 | 0.004142 |
| GO:0006904 | vesicle docking involved in exocytosis | 1.37% (2/146) | 4.99 | 0.001589 | 0.004142 |
| GO:0140029 | exocytic process | 1.37% (2/146) | 4.99 | 0.001589 | 0.004142 |
| GO:0043170 | macromolecule metabolic process | 13.7% (20/146) | 1.04 | 0.001684 | 0.004323 |
| GO:0051640 | organelle localization | 1.37% (2/146) | 4.77 | 0.00221 | 0.005589 |
| GO:0016877 | ligase activity, forming carbon-sulfur bonds | 1.37% (2/146) | 4.58 | 0.002926 | 0.00719 |
| GO:0008641 | ubiquitin-like modifier activating enzyme activity | 1.37% (2/146) | 4.58 | 0.002926 | 0.00719 |
| GO:0005488 | binding | 26.03% (38/146) | 0.62 | 0.003504 | 0.008488 |
| GO:0009058 | biosynthetic process | 10.27% (15/146) | 1.12 | 0.003719 | 0.008883 |
| GO:0044237 | cellular metabolic process | 15.75% (23/146) | 0.85 | 0.003836 | 0.009039 |
| GO:0034641 | cellular nitrogen compound metabolic process | 10.96% (16/146) | 1.07 | 0.003929 | 0.009133 |
| GO:0044238 | primary metabolic process | 16.44% (24/146) | 0.75 | 0.00783 | 0.017956 |
| GO:0071704 | organic substance metabolic process | 17.12% (25/146) | 0.71 | 0.009411 | 0.021298 |
| GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4.11% (6/146) | 1.73 | 0.009735 | 0.021747 |
| GO:0019781 | NEDD8 activating enzyme activity | 0.68% (1/146) | 6.58 | 0.010472 | 0.022515 |
| GO:0019008 | molybdopterin synthase complex | 0.68% (1/146) | 6.58 | 0.010472 | 0.022515 |
| GO:0045116 | protein neddylation | 0.68% (1/146) | 6.58 | 0.010472 | 0.022515 |
| GO:0006468 | protein phosphorylation | 3.42% (5/146) | 1.83 | 0.01336 | 0.02837 |
| GO:0016310 | phosphorylation | 3.42% (5/146) | 1.78 | 0.015442 | 0.03239 |
| GO:0004672 | protein kinase activity | 3.42% (5/146) | 1.71 | 0.018705 | 0.038761 |
| GO:0051539 | 4 iron, 4 sulfur cluster binding | 0.68% (1/146) | 5.58 | 0.020835 | 0.042662 |